3 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 7 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Active not recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 1 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Withdrawn 1 |
Follow Renal Transplant Rejection: new trials by email Literature Review of Renal Transplant Rejection trials Research Report on Renal Transplant Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation Tacrolimus - Renal Transplant Rejection, Renal Transplant Infection | Phase 1 / Phase 2 | Withdrawn | University College, London | 2023-02-20 | 2023-05-11 | |
| Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor Donor CD34+ and CD3+ cells - Renal Transplant Rejection, Tolerance | Phase 1 / Phase 2 | Recruiting | Jeffrey Veale, MD | 15 | 2019-11-06 | 2026-05-08 |
| Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection Fostamatinib - Renal Transplant Rejection | Phase 1 / Phase 2 | Active not recruiting | Imperial College London | 8 | 2019-05-08 | 2024-11-25 |
| Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection Sonazoid, contrast enhanced ultrasonography - Renal Transplant Rejection | Phase 2 | Completed | Brigham and Women's Hospital | 8 | 2018-05-30 | 2023-03-06 |
| Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI) Antithymocyte Immunoglobulin (Rabbit) - Renal Transplant Rejection | Phase 2 | Completed | Prof. Dr. Petra Reinke | 68 | 2016-12-15 | 2021-01-29 |
| Belimumab Impacting Transplant Eligibility belimumab, Bortezomib, Rituximab - Renal Transplant Rejection | Phase 1 / Phase 2 | Completed | E. Steve Woodle | 11 | 2015-06-01 | 2019-04-22 |
| Mesenchymal Stromal Cell Therapy in Renal Recipients Mesenchymal Stromal Cells - Renal Transplant Rejection, Fibrosis | Phase 2 | Unknown | Leiden University Medical Center | 70 | 2014-03-01 | 2020-09-17 |
Fibrosis (1)
Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Tacrolimus (2) · Antilymphocyte Serum (1) · Bortezomib (1) · Infliximab (1) · Mycophenolic Acid (1) · Plasmapheresis (1) · Prednisolone (1) · Rituximab (1) · Sonazoid (1) · belimumab (1) · fostamatinib (1)
Brigham and Women's Hospital (1) · E. Steve Woodle (1) · Imperial College London (1) · Jeffrey Veale, MD (1) · Leiden University Medical Center (1) · Prof. Dr. Petra Reinke (1) · University College, London (1)
United States (3) · Germany (1) · Netherlands (1) · United Kingdom (1)
E. Steve Woodle, MD (1) · Frederick Tam, MBBChir (1) · Jeffrey Veale, MD (1) · Marlies EJ Reinders, MD/PhD (1) · Ondrej Viklicky, PhD, MD (1) · Reinke Reinke, PhD, MD (1) · Reza Abdi, MD (1)
PMID 23349326, PMID 25491391, PMID 31335773, PMID 37426430, PMID 37525369, PMID 40374867
2018 (1)